The space race is back — and this time, it's a direct competition between the United States and China for dominance on the lunar surface.
NASA's Artemis II mission recently made history when four astronauts flew farther into deep space than any humans before them, looping past the moon's far side. The mission sets the stage for Artemis IV to attempt a crewed lunar landing in 2028, marking America's first return to the moon in over 50 years.
Meanwhile, China is aggressively developing its own crewed lunar program with a target landing date of 2030. The full mission architecture is already in progress, including the Long March-10 heavy-lift rocket, the Mengzhou crewed spacecraft capable of carrying up to seven astronauts, and the Lanyue lunar lander. Under the current plan, two astronauts would descend to the lunar surface, collect samples, and return to orbit before heading back to Earth.
China has demonstrated serious momentum. It became the first nation to retrieve rock samples from both the near and far sides of the moon using robotic missions. Early abort and lander tests have also shown promising results, though experts say the pace of hardware certification will need to increase significantly to meet the 2030 deadline. Despite the challenges, analysts at the Center for Strategic and International Studies consider it "very plausible" that China stays on schedule, noting that Beijing has historically met its space milestones.
Beyond the technical competition, the geopolitical implications are enormous. The U.S. leads the Artemis Accords coalition for lunar governance, while China and Russia head the rival International Lunar Research Station initiative. Experts warn that whichever nation establishes a stronger long-term presence on the moon will gain significant strategic influence in space diplomacy, technology leadership, and national prestige for decades to come.


Trump May Delay Iran Military Strike If Diplomatic Deal Shows Promise
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Todd Blanche Defends Trump's Authority to Direct Federal Investigations
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Britain Courts Anthropic Amid US Defense Department Dispute
FCC Moves to Ban All Chinese Labs From Testing U.S. Electronics
Haiti Election 2025: Voter Registration Delayed Amid Ongoing Security Crisis
ICE Officer-Involved Shooting in Northern California After Suspect Rams Vehicle
Xi Jinping Pushes Demand-Driven Strategy to Modernize China's Service Sector
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Apple Turns 50: From Garage Startup to AI Crossroads 



